Inventor · disambiguated record
Martin Rowbottom
Also filed as: ROWBOTTOM MARTIN · ROWBOTTOM MARTIN W
41 granted patents·12 pending applications·203 citations·filing 2001–2025
97Inventor score
Files withNEUROCRINE BIOSCIENCES INC18PHARMAKEA INC16AMBIT BIOSCIENCES CORP8BEATON GRAHAM4HADD MICHAEL J2
Top patents by PatentIndex Score
53 records- 0195US10150732B2Fluorinated lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2017·Granted Dec 11, 2018·10 cites·24 claims
- 0294US9422310B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2015·Granted Aug 23, 2016·14 cites·19 claims
- 0390US10570094B2Fluorinated lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2018·Granted Feb 25, 2020·4 cites·21 claims
- 0490US8618289B2RAF kinase modulator compounds and methods of use thereofABRAHAM SUNNY·Filed 2009·Granted Dec 31, 2013·22 cites·26 claims
- 0589US9320739B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2015·Granted Apr 26, 2016·6 cites·11 claims
- 0689US8084614B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2008·Granted Dec 27, 2011·12 cites·17 claims
- 0789US6608197B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2001·Granted Aug 19, 2003·31 cites·37 claims
- 0888US10774069B2Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of makingPHARMAKEA INC·Filed 2017·Granted Sep 15, 2020·2 cites·9 claims
- 0988US10766860B2Lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2016·Granted Sep 8, 2020·4 cites·11 claims
- 1088US8969587B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2013·Granted Mar 3, 2015·8 cites·14 claims
- 1188US7462625B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2006·Granted Dec 9, 2008·9 cites·20 claims
- 1287US7229995B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Granted Jun 12, 2007·10 cites·20 claims
- 1386US10588900B2Quinolinone lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2017·Granted Mar 17, 2020·2 cites·20 claims
- 1485US10941159B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2019·Granted Mar 9, 2021·1 cites·4 claims
- 1585US8481738B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2011·Granted Jul 9, 2013·6 cites·9 claims
- 1683US10336769B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2017·Granted Jul 2, 2019·2 cites·1 claims
- 1783US8952161B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2013·Granted Feb 10, 2015·4 cites·16 claims
- 1883US6872728B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Granted Mar 29, 2005·16 cites·86 claims
- 1981US9926318B2Tetracyclic autotaxin inhibitorsPHARMAKEA INC·Filed 2014·Granted Mar 27, 2018·4 cites·17 claims
- 2080US11072585B2Fluorinated lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2019·Granted Jul 27, 2021·1 cites·17 claims
- 2180US11058676B2Quinolinone lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2019·Granted Jul 13, 2021·1 cites·22 claims
- 2280US7179815B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Feb 20, 2007·11 cites·18 claims
- 2380US7015226B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Mar 21, 2006·12 cites·28 claims
- 2478US10053430B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2017·Granted Aug 21, 2018·1 cites·2 claims
- 2577US9725465B2Biaryl acetamide compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Aug 8, 2017·3 cites·4 claims
- 2676US11713324B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Aug 1, 2023·0 cites·2 claims
- 2776US2025282792A1Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2875US9730937B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2016·Granted Aug 15, 2017·1 cites·19 claims
- 2972US9452167B2Heterocyclic compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Sep 27, 2016·1 cites·20 claims
- 3071US6750350B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2002·Granted Jun 15, 2004·4 cites·5 claims
- 3162US11358936B2Lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2020·Granted Jun 14, 2022·0 cites·11 claims
- 3260US11459309B2Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of makingPHARMAKEA INC·Filed 2020·Granted Oct 4, 2022·0 cites·5 claims
- 3356US8263588B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2008·Granted Sep 11, 2012·0 cites·18 claims
- 3456US6921761B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Jul 26, 2005·0 cites·20 claims
- 3555US8952058B2Heterocyclic compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2012·Granted Feb 10, 2015·0 cites·13 claims
- 3655US7081459B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Granted Jul 25, 2006·0 cites·14 claims
- 3755US7067509B2Melanin-concentrating hormone receptor antagonists and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Jun 27, 2006·1 cites·59 claims
- 3852US9938261B2Heterocyclic compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2016·Granted Apr 10, 2018·0 cites·23 claims
- 3950US2018162859A1Tetracyclic autotaxin inhibitorsPHARMAKEA INC·Filed 2018·Application pending·0 cites
- 4049US2023102554A1Heterocyclic kinase inhibitors and products and uses thereofGB002 INC·Filed 2020·Application pending·0 cites
- 4148US8507536B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2012·Granted Aug 13, 2013·0 cites·16 claims
- 4246US9850203B2Autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2014·Granted Dec 26, 2017·0 cites·20 claims
- 4343US11345676B2Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compoundsPHARMAKEA INC·Filed 2018·Granted May 31, 2022·0 cites·17 claims
- 4442US2006178403A1Melanin-concentrating hormone receptor antagonists and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 4542US2019192697A1Chemical probes of lysyl oxidask-like 2 and uses thereofPHARMAKEA INC·Filed 2017·Application pending·0 cites
- 4640US2013303533A1Azolopyridine and azolopyrimidine compounds and methods of use thereofCHAO QI·Filed 2011·Application pending·0 cites
- 4740US2005256124A1Melanin-concentrating hormone receptor antagonists and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Application pending·0 cites
- 4839US2018186755A1Lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2016·Application pending·0 cites
- 4939US2018215727A1Lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2016·Application pending·0 cites
- 5038US2013296363A1Quinoline and isoquinoline derivatives for use as jak modulatorsFARAONI RAFFAELLA·Filed 2011·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Martin Rowbottom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →